Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00106431
Status:
COMPLETED
Last Update Posted:
2019-10-30
First Post:
2005-03-24
Brief Title:
A Single Agent Phase II Study of Romidepsin Depsipeptide FK228 in the Treatment of Cutaneous T-cell Lymphoma CTCL
Sponsor:
Organization:
Celgene